![© Daniel Novotny Gerald Gartlehner](/.imaging/mte/duk-theme/peoplePicker/dam/MitarbeiterInnen/G-I/Gartlehner_Gerald_Download.jpg/jcr:content/Gartlehner_Gerald_c_Daniel_Novotny.jpg)
Univ.-Prof. Dr. Gerald Gartlehner, MPH
Head of Department - Department for Evidence-based Medicine and Evaluation
-
gerald.gartlehner@donau-uni.ac.at
-
+43 2732 893-2910
-
To contact form
-
Campus Krems, Tract X, 1st Floor, 009
- University for Continuing Education Krems
- Department for Evidence-based Medicine and Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Austria
Projects (Extract Research Database)
Running projects
Knowledge user involvement in rapid reviews
Duration: 15/01/2024–31/07/2024
Principle investigator for the project (University for Continuing Education Krems): Barbara Nußbaumer-Streit
Duration: 01/07/2023–30/06/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen
Nachhaltige Gesundheitsversorgung im Spannungsfeld zwischen Tradition und Evidenzbasierung
Duration: 13/04/2023–31/03/2025
Principle investigator for the project (University for Continuing Education Krems): Brigitte Piso
Funding: Sonstige
Becoming Equipped to Tackle Epidemics Right (BETTER)
Duration: 01/03/2023–28/02/2026
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: sonstige öffentlich-rechtliche Einrichtungen (Körperschaften, Stiftungen, Fonds)
Pharmacological Treatment of Acute Episodic Migraine Attacks
Duration: 15/02/2023–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige
Interpretation of Non-significant Differences
Duration: 01/12/2022–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Duration: 01/01/2017–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige
Completed projects
Duration: 01/07/2022–30/06/2023
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen
WO24-Targeted Immune Modulators - Ulcerative Colitis and Crohn Diseases: Systematic Review Update
Duration: 01/07/2022–30/04/2023
Principle investigator for the project (University for Continuing Education Krems): Andreea Dobrescu
Funding: andere internationale Organisationen
Post-Acute Sequelae of SARS CoV-2 infection (RECOVER)
Duration: 01/04/2022–31/10/2022
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige
European Partnership on Competencies for High Value Cost Conscious Care 2018
Duration: 01/10/2018–31/05/2022
Principle investigator for the project (University for Continuing Education Krems): Irma Klerings
Funding: EU
Program: ERASMUS+
Duration: 10/06/2020–31/03/2022
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen
Systematischer Review Point of Care Ultrasound
Duration: 11/10/2018–31/03/2021
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen
DIMDI - Erstellung von HTA-Projekten
Duration: 01/12/2013–11/12/2019
Principle investigator for the project (University for Continuing Education Krems): Anna Glechner
Funding: Sonstige
Program: ---
Rapid Reviews - Single Screening RCT classifier
Duration: 01/12/2018–31/10/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Private (Stiftungen, Vereine etc.)
Duration: 01/10/2018–30/09/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Program: ---
Surgery or embolization for varicoceles in subfertile men
Duration: 01/09/2018–01/09/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: CDG
Program: ---
Publications (Extract Research Database)
Affengruber, L.; Nussbaumer-Streit, B.; Hamel, C.; Van der Maten, M.; Thomas, J.; Mavergames, C.; Spijker, R.; Gartlehner, G. (2024). Rapid review methods series: Guidance on the use of supportive software. BMJ Evid Based Med, Online ahead of print.: doi: 10.1136/bmjebm-2023-112530.
Dobrescu, A.; Constantin, A.M.; Pinte, L.; Chapman, A.; Ratajczak, P.; Klerings, I.; Emprechtinger, R.; Allegranzi, B.; Zingg, W.; Grayson, M.L.; Toldeo, J.; Gartlehner, G.; Nussbaumer-Streit, B.; (2024). Effectiveness and safety of measures to prevent infections and other complications associated with peripheral intravenous catheters: A systematic review and meta-analysis. Clinical Infectious Diseases, Online ahead of print: doi: 10.1093/cid/ciae195.
Dobrescu, A.I.; Persad, E.; Klerings, I.; Gartlehner, G. (2024). Update Alert: Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians. Ann Intern Med, onine ahead of print: 10.7326/L23-0441.
Garritty, C.; Hamel, C.; Trivella, M.; Gartlehner, G.; Nussbaumer-Streit, B.; Devane, D.; Kamel, C.; Griebler, U.; King, V.J.; Cochrane Rapid Reviews Methods Group (2024). Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness. BMJ, 384:e076335: 1-13
Gartlehner, G.; Kahwati, L.; Hilscher, R.; Thomas, I.; Kugley, S.; Crotty, K.; Viswanathan, M.; Nussbaumer-Streit, B.; Booth, G.; Erskine, N.; Konet, A.; Chew, R. (2024). Data extraction for evidence synthesis using a large language model: A proof-of-concept study. Research Synthesis Methods, Online ahead of print.: 1-14
Ledinger, D.; Nussbaumer-Streit, B.; Gartlehner, G. (2024). WHO-Leitlinie: Versorgung von Frühgeborenen und Neugeborenen mit niedrigem Geburtsgewicht. Gesundheitswesen, Issue EFirst: DOI: 10.1055/a-2251-5686
Piso, B.; Nussbaumer-Streit, B.; Gartlehner, G. (2024). WHO-Leitlinie zur psychischen Gesundheit am Arbeitsplatz. Gesundheitswesen, 86: 216-219
Puljak, L; Bala, M. M.; Zajac, J.; Meštrovic, T.; Buttigieg, S.; Yanakoulia, M.; Briel, M.; Lunny, C.; Lesniak, W.; Poklepovic Pericic, T.; Alonso-Coello, P.; Clarke, M.; Djulbegovic, B.; Gartlehner, G.; Giannakou, K.; Glenny, A.; Glenton, C.; Guyatt, G.; Hemkens, L. G.; Ioannidis, J. P. A.; Jaeschke, R.; Juhl Jørgensen, K.; Castro Martins-Pfeifer, C.; Marusic, A.; Mbuagbaw, L.; et. al. (2024). Methods proposed for monitoring the implementation of evidence-based research: a cross-sectional study. Journal of Clinical Epidemiology, 168: 1-11
Torbahn, G.; Jones, A.; Griffiths, A.; Matu, J.; Metzendorf, M.; Ells, L.J.; Gartlehner, G.; Kelly, A.S.; Weghuber, D.; Brown, T. (2024). Pharmacological interventions for the management of children and adolescents living with obesity—An update of a Cochrane systematic review with meta-analyses. Pediatric Obesity, e13113: https://doi.org/10.1111/ijpo.13113
Tran, V.T.; Gartlehner, G.; Yaacoub, S.; Boutron, I.; Schwingshackl, L.; Stadelmaier, J.; Sommer, I.; Alebouyeh, F.; Afach, S.; Meerpohl, J.; Ravaud, P. (2024). Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analyses. Ann Intern Med, Online ahead of print.: doi: 10.7326/M23-3389
Ovelman, C.; Kugley, S.; Gartlehner, G.; Viswanathan, M. (2024). The use of a large language model to create plain language summaries of evidence reviews in healthcare: A feasibility study. Cochrane Evidence Synthesis and Methods, 2:e12041: 1-7
Affengruber, L.; Wagner, G.; Dobrescu, A.; Toromanova, A.; Chapman, A.; Persad, E.; Klerings, I.; Gartlehner, G. (2023). Values and Preferences of Patients With Depressive Disorders Regarding Pharmacologic and Nonpharmacologic Treatments. A Rapid Review. Annals of Internal Medicine, 176(2): 217-223.
Crotty, K.; Viswanathan, M.; Kennedy, S.; Edlund, M.J.; Ali, R.; Siddiqui, M.; Wines, R.; Ratajczak, P.; Gartlehner, G. (2023). Psychotherapies for the treatment of borderline personality disorder: A systematic review. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, online ahead of print: 1-21
Dobrescu, A.; Chapman, A.; Affengruber, L.; Persad, E.; Toromanova, A.; Wagner, G.; Klerings, I.; Emprechtinger, R.; Gartlehner, G. (2023). Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder. A Rapid Review. Annals of Internal Medicine, 176(2): 212-216
Gartlehner, G.; Dobrescu, A.; Chapman, A.; Toromanova, A.; Emprechtinger, R.; Persad, E.; Affengruber, L.; Pieh, C.; Klerings, I.; Wagner, G. (2023). Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder. A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians. Annals of Internal Medicine, 176: 196-211
Gartlehner, G.; Kahwati, L. (2023). Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons—Reply. JAMA, 329(11): 943
Gartlehner, G.; Nussbaumer-Streit, B.; Devane, D.; Kahwati, L.; Viswanathan, M.; King, V.J.; Qaseem, A.; Akl, E.; Schuenemann, H.J. (2023). Rapid reviews methods series: Guidance on assessing the certainty of evidence. BMJ Evidence-Based Medicine, epub: 1-5
Gartlehner, G.; Persad, E.; Ledinger, D.; Chapman, A.; Gadinger, A.; Feyertag, J.; Emprechtinger, R. (2023). Beyond statistical significance: nuanced interpretations of statistically nonsignificant results were rare in Cochrane reviews – a metaepidemiological study. Journal of Clinical Epidemiology, 160: 46-53
Gartlehner, G.; Schernhammer, E.; Lax, S.F.; Preusser, M.; Bachler, H.; Tietzer, H.; Kletecka-Pulker, M.; Turnher, H.; Siebert, U. (2023). Screening for colorectal cancer. Wiener klinische Wochenschrift, 2023: 1-9
Glechner, A.; Wagner, G.; Mitus, J.W.; Teufer, B.; Klerings, I.; Böck, N.; Grillich, L.; Berzaczy, D.; Helbich, T.H.; Gartlehner, G.; (2023). Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database of Systematic Reviews, 3: 1-78
Lectures (Extract Research Database)
AI in Health Services Research
AcademyHealth’s Expert Meeting, 17/06/2024
Does data extraction work with large language models and/or AI-based automation tools?
3rd Methods Form, Cochrane Germany Foundation, 14/06/2024
AI for Evidence Synthesis
Kayser Permanente Evidence-based Practice Center meeting, 05/03/2024
AI Applications in Evidence Synthesis
Cochrane US Network Meeting, 01/03/2024
Gute Studien-Schlechte Studien: Ivermectin bei COVID-19.
Podiumsdiskussion: Vielgeschmähtes Ivermectin - Pferde-Entwurmungsmittel oder wirksames Corona-Medikament?, 23/02/2024
Data Synthesis and Rating the Certainty of Evidence in Rapid Reviews
Cochrane Training, Learning Live, 25/01/2024
Zwischen Fakten und Fiktion: Die Corona-Pandemie und Falschinformationen
MeinMed, 22/11/2023
Rauchen und Schokolade gegen COVID-19
Berufsbildende Schulen Weyer, 16/11/2023
Covid-19: Eine Pandemie zwischen Fakten und Falschinformationen
Berufsbildende Schulen Weyer, 16/11/2023
Workshop on Guideline Development using GRADE
WHO, 12/10/2023
Tags